Dosage Modification of Traditional Chinese Medicine Prescriptions: An Analysis of Two Randomized Controlled Trials

Traditional Chinese medicine (TCM) prescriptions lack standardization due to the complex composition of the prescribed herbs, the unclear mechanism of the formulas, and a lack of scientific data to support the dose-response relationship. Here, we proposed a new clinical strategy of dosage modification for TCM prescriptions to evaluate the clinical efficacy and guide the clinical medication. This study used two TCM prescriptions for the treatment of newly diagnosed type 2 diabetes mellitus (T2DM) to explore the key indications and the most appropriate critical values of dosage modification by analyzing two randomized controlled trials (RCTs). In this study, the indications refer to a change in the indicators from baseline at a certain time point (week 4, week 8, week 12), which could predict the change in outcome indicators, and the critical values refer to the change ranges closely related to the decrease in HbA1c at week 12. In Study 1, the correlation analysis between the change range of indicators at three time points (weeks 4, 8, and 12) from baseline and the decrease in HbA1c at week 12 from baseline (HbA1c 012) was carried out to screen the related indications. Next, we evaluate the related indications and the respective critical values to determine the key indicators, indications, and the most appropriate critical value. We conducted a correlation between the change range of key indicators (obtained from the result of Study 1) at three time points from baseline and HbA1c 012 to screen the key indications in the drug group, high-dose group, and low-dose group in Study 2. Key indications with critical values were determined to investigate the most appropriate critical value in the three groups separately. In Study 1, the key indicator was FBG, the key indication was FBG 04, and the most appropriate critical value was 0.5 mmol/L. In Study 2, the key indication was FBG 04 and the most appropriate critical value was 0.6 mmol/L in the drug group. In the high-dose group, the key indication was FBG 04, and the most appropriate critical value was 0.3 mmol/L. In the low-dose group, the key indication was FBG08, and the most appropriate critical value was 0.1 mmol/L. In addition, we summarized a verification strategy for dosage modification.

[1]  T. Si,et al.  Dose-Dependent Efficacy of Aripiprazole in Treating Patients With Schizophrenia or Schizoaffective Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2021, Frontiers in Psychiatry.

[2]  Myung-Haeng Hur,et al.  The Effects of Dietary Education Interventions on Individuals with Type 2 Diabetes: A Systematic Review and Meta-Analysis , 2021, International journal of environmental research and public health.

[3]  M. Fayon,et al.  The First 1000 Days: Impact of Prenatal Tobacco Smoke Exposure on Hospitalization Due to Preschool Wheezing , 2021, Healthcare.

[4]  Ning Wang,et al.  Network Pharmacology–Based Analysis and Experimental Exploration of Antidiabetic Mechanisms of Gegen Qinlian Decoction , 2021, Frontiers in Pharmacology.

[5]  G. Cheng,et al.  The Relationship Between Late Morbidity and Dose–Volume Parameter of Rectum in Combined Intracavitary/Interstitial Cervix Cancer Brachytherapy: A Mono-Institutional Experience , 2021, Frontiers in Oncology.

[6]  Libin Zhan,et al.  The Effects of Erchen Decoction on Gut Microbiota and Lipid Metabolism Disorders in Zucker Diabetic Fatty Rats , 2021, Frontiers in Pharmacology.

[7]  Yongsheng Fan,et al.  The Anti-Inflammatory Effect of Zhibaidihuang Decoction on Recurrent Oral Ulcer with Sirt1 as the Key Regulatory Target , 2021, Evidence-based complementary and alternative medicine : eCAM.

[8]  Maoyi Yang,et al.  Effect of Huang-Lian Jie-Du Decoction on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis , 2021, Frontiers in Pharmacology.

[9]  Xueping Zhu,et al.  Use of Network Pharmacology to Explore the Mechanism of Gegen (Puerariae lobatae Radix) in the Treatment of Type 2 Diabetes Mellitus Associated with Hyperlipidemia , 2021, Evidence-based complementary and alternative medicine : eCAM.

[10]  K. Sultanem,et al.  Examination of the Dose-Effect Relationship of Radiation-Induced Hypopituitarism: Results of a Case-Control Study , 2021, Advances in radiation oncology.

[11]  Cheng Wang,et al.  Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease. , 2021, European journal of pharmacology.

[12]  A. R. Giuliani,et al.  Potential Therapeutic Effects of Curcumin on Glycemic and Lipid Profile in Uncomplicated Type 2 Diabetes—A Meta-Analysis of Randomized Controlled Trial , 2021, Nutrients.

[13]  Boxun Zhang,et al.  The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus , 2020, Frontiers in Pharmacology.

[14]  W Yun,et al.  Investigation of the Mechanism of Traditional Chinese Medicines in Angiogenesis through Network Pharmacology and Data Mining , 2020, Evidence-based complementary and alternative medicine : eCAM.

[15]  Shaomin Li,et al.  Systematic Evaluation of Levodopa Effect on Visual Improvement in Amblyopia: A Meta-analysis. , 2019, Clinical neuropharmacology.

[16]  Lan-Yan Yang,et al.  The efficacy and safety of concentrated herbal extract granules, YH1, as an add-on medication in poorly controlled type 2 diabetes: A randomized, double-blind, placebo-controlled pilot trial , 2019, PloS one.

[17]  Liping Liu,et al.  Effects of sang-qi granules on blood pressure and endothelial dysfunction in stage I or II hypertension: study protocol for a randomized double-blind double-simulation controlled trial , 2019, Trials.

[18]  Jihan Huang,et al.  Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study , 2019, Scientific Reports.

[19]  Liping Zhao,et al.  Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial , 2018, mBio.

[20]  Yazhen Chen,et al.  Evaluation of antioxidant activities of ethanol extract from Ligusticum subjected to in-vitro gastrointestinal digestion. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[21]  X. Tong,et al.  A new method to evaluate the dose-effect relationship of a TCM formula Gegen Qinlian Decoction: “Focus” mode of integrated biomarkers , 2017, Acta Pharmacologica Sinica.

[22]  Chong-Zhi Wang,et al.  The Efficacy and Safety of Chinese Herbal Medicine Jinlida as Add-On Medication in Type 2 Diabetes Patients Ineffectively Managed by Metformin Monotherapy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial , 2015, PloS one.

[23]  Yuzhi Du,et al.  [Study on safety of Tibetan medicine zuotai and preliminary study on clinical safety of its compound dangzuo]. , 2014, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[24]  Jingchun Zhang,et al.  Chinese Herbal Medicine Bushen Qinggan Formula for Blood Pressure Variability and Endothelial Injury in Hypertensive Patients: A Randomized Controlled Pilot Clinical Trial , 2014, Evidence-based complementary and alternative medicine : eCAM.

[25]  Chong-Zhi Wang,et al.  The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: a randomized double‐blind placebo‐controlled trial , 2013, Diabetes, obesity & metabolism.

[26]  Xiao-Feng Wang,et al.  [Study on the correlation between Chinese medicine syndrome types of the Uighur and Han people and levels of blood lipids and fibrinogen in premature coronary heart disease patients]. , 2012, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[27]  Hong-Jun Yang,et al.  Research ideas and strategies on the dose-effect relationship of traditional Chinese medicine prescriptions and herbs. , 2012, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[28]  Liming Chen,et al.  JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial , 2010, Trials.

[29]  Haiying Yao,et al.  Clinical effect and safety evaluation of different dosage of Rituximab combined with Cyclophosphamide in treatment of refractory immune Thrombocytopenia , 2020, Pakistan journal of medical sciences.

[30]  X. Tong,et al.  Clinical Strategy for Optimal Traditional Chinese Medicine (TCM) Herbal Dose Selection in Disease Therapeutics: Expert Consensus on Classic TCM Herbal Formula Dose Conversion. , 2015, The American journal of Chinese medicine.

[31]  Warren J. Gasper,et al.  The Carotid Artery , 2012 .

[32]  Tong Xiao-Lin Effect of Tangminling Pills on β-cell Function of Patients with Type 2 Diabetic Combined Metabolism Syndrome , 2010 .

[33]  Bai Yu,et al.  Comparative clinical trial of the traditional Chinese medicine hypoglycemic composing prescription and metformin in the treatment of type 2 diabetes mellitus , 2008 .